Literature DB >> 3263349

Histamine and related substances influence neurotransmission in the semicircular canal.

G D Housley1, C H Norris, P S Guth.   

Abstract

Histamine and other imidazole-containing substances were found to increase ampullar nerve afferent firing rate while both H1 and H2 histamine antagonists effectively inhibited ampullar nerve activity. A specific inhibitor of histidine decarboxylase, the enzyme which catalyses the synthesis of histamine, reduced ampullar nerve firing in a dose-dependent manner. These observations suggest a physiological role for histamine in the inner ear. Maintenance of a response to histamine after de-efferentation of the crista ampullaris supports the hypothesis that the site of action is the hair cell; antagonism of the histamine response by a cholinergic antagonist, atropine, and antagonism of a cholinergically mediated facilitation by the histaminergic antagonist pyrilamine, indicate that the site of action may involve the acetylcholine receptor complex on the crista ampullaris hair cells. The observation that imidazole-containing compounds cause significant effects on semicircular canal neurotransmission provides an important finding with regard to the site of action of antihistamines used for the treatment of vertigo and motion sickness.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263349     DOI: 10.1016/0378-5955(88)90043-3

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  10 in total

1.  Benign paroxysmal positional vertigo: a study of two manoeuvres with and without betahistine.

Authors:  M Cavaliere; G Mottola; M Iemma
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-04       Impact factor: 2.124

Review 2.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

3.  Effect of the novel histamine H4 receptor antagonist SENS-111 on spontaneous nystagmus in a rat model of acute unilateral vestibular loss.

Authors:  Mathieu Petremann; Cindy Gueguen; Viviana Delgado Betancourt; Eric Wersinger; Jonas Dyhrfjeld-Johnsen
Journal:  Br J Pharmacol       Date:  2019-08-28       Impact factor: 8.739

4.  Safety, tolerability, pharmacokinetics and pharmacokinetic-pharmacodynamic modelling of the novel H4 receptor inhibitor SENS-111 using a modified caloric test in healthy subjects.

Authors:  Frédéric Venail; Pierre Attali; Eric Wersinger; Roberto Gomeni; Sonia Poli; Sebastien Schmerber
Journal:  Br J Clin Pharmacol       Date:  2018-10-01       Impact factor: 4.335

Review 5.  Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action.

Authors:  M Lacour; O Sterkers
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 6.  Management of peripheral vertigo with antihistamines: New options on the horizon.

Authors:  Jonas Dyhrfjeld-Johnsen; Pierre Attali
Journal:  Br J Clin Pharmacol       Date:  2019-07-22       Impact factor: 4.335

7.  Does Mucosal Chronic Otitis Media Leads to Sensorineural Hearing Loss.

Authors:  Chandan Kumari Thakur; Ankur Gupta; Ashok Kumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-11-08

8.  Neuropharmacology of vestibular system disorders.

Authors:  Enrique Soto; Rosario Vega
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

Review 9.  Current concepts in the pathogenesis and treatment of chronic suppurative otitis media.

Authors:  Rahul Mittal; Christopher V Lisi; Robert Gerring; Jeenu Mittal; Kalai Mathee; Giri Narasimhan; Rajeev K Azad; Qi Yao; M'hamed Grati; Denise Yan; Adrien A Eshraghi; Simon I Angeli; Fred F Telischi; Xue-Zhong Liu
Journal:  J Med Microbiol       Date:  2015-08-05       Impact factor: 2.472

10.  Effects of Several Therapeutic Agents on Mammalian Vestibular Function: Meclizine, Diazepam, and JNJ7777120.

Authors:  Choongheon Lee; Timothy A Jones
Journal:  J Assoc Res Otolaryngol       Date:  2021-05-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.